Home | Welcome to Contract Pharma   
Last Updated Thursday, October 30 2014
Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published January 7, 2011
Effie Toshav, J.D., has been appointed senior vice president and general counsel at AVI BioPharma, effective January 10th. Read More »
Published May 4, 2010
Vetter, a provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, have signed a preferred partnership agreement. Read More »
Published May 23, 2008
DOR BioPharma has opened a new corporate office in the UK. The new office gives DOR a presence in the EU to better facilitate the Named Patient Access program that will be administered by IDIS, also based in the UK. Serving as the company's official… Read More »
Published September 26, 2007
Baxter BioPharma Solutions recently completed the lyophilization capacity expansion at their cytotoxic contract manufacturing facility in Halle, Germany. The expansion increased their total cytotoxic lyophilization capacity to four dedicated lyophili… Read More »
Published August 29, 2007
PDL BioPharma, Inc., following a business and portfolio review, has changed its strategic focus to the discovery and development of novel antibodies in oncology and select immunological diseases. According to a company statement, it will realign its… Read More »
Published May 15, 2007
Dr. John Yates has been appointed to the newly created position of chief medical officer at Array BioPharma, Inc. Dr. Yates will oversee the medical strategy and clinical development of the company's cancer and inflammation pipeline. "John… Read More »
Published December 13, 2006
Holmes Biopharma, Inc. has signed a letter of intent to purchase an existing pharmaceutical development, clinical manufacture, biotechnology, and analytical laboratory business located in the eastern U.S. The name and terms of the acquisition will be… Read More »
Published October 6, 2006
Array BioPharma, Inc. has appointed April H. Teitelbaum, M.D., MS, FACP, to the newly created position of vice president of clinical development, oncology. Dr. Teitelbaum will oversee the medical strategy and clinical development of the company's onc… Read More »
Published April 11, 2006
Array BioPharma and AstraZeneca have selected a third compound for their small molecule MEK anti-cancer program, triggering a $1 million milestone payment by AstraZeneca. The second compound was selected in January 2006, also triggering a $1 million… Read More »
Hantson named chief executive officer Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On